Allogenic Umbilical Cord-Derived Mesenchymal Stromal Cells Sustain Long-Term Therapeutic Efficacy Compared With Low-Dose Interleukin-2 in Systemic Lupus Erythematosus

OBJECTIVES: Mesenchymal stromal cells (MSCs) and low-dose interleukin-2 (IL-2) both have demonstrated efficacy in treating systemic lupus erythematosus (SLE). The aim of this study is to conduct a head-to-head comparison between the 2 treatments and provide insights for clinical applications. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Zhouli, Wang, DanDan, Jing, Lijuan, Wen, Xin, Xia, Nan, Ma, Wenjuan, Zhang, Xueyi, Jin, Ziyi, Shen, Wei, Yao, Genhong, Chen, Weiwei, Tang, Xiaojun, Geng, Linyu, Li, Hui, Li, Xiaojing, Ding, Shuai, Liang, Jun, Feng, Xuebing, Zhang, Huayong, Liu, Shanshan, Li, Wenchao, Sun, Lingyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Enabling Technologies for Cell-Based Clinical Translation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10346415/
https://www.ncbi.nlm.nih.gov/pubmed/37279956
http://dx.doi.org/10.1093/stcltm/szad032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10346415/
https://www.ncbi.nlm.nih.gov/pubmed/37279956
http://dx.doi.org/10.1093/stcltm/szad032

Ejemplares similares